Cargando…

Metabolism‐based therapies for epilepsy: new directions for future cures

OBJECTIVE: Thousands of years after dietary therapy was proposed to treat seizures, how alterations in metabolism relates to epilepsy remains unclear, and metabolism‐based therapies are not always effective. METHODS: We consider the state of the science in metabolism‐based therapies for epilepsy acr...

Descripción completa

Detalles Bibliográficos
Autores principales: Cervenka, Mackenzie, Pascual, Juan M., Rho, Jong M., Thiele, Elizabeth, Yellen, Gary, Whittemore, Vicky, Hartman, Adam L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351378/
https://www.ncbi.nlm.nih.gov/pubmed/34247456
http://dx.doi.org/10.1002/acn3.51423
_version_ 1783735961748766720
author Cervenka, Mackenzie
Pascual, Juan M.
Rho, Jong M.
Thiele, Elizabeth
Yellen, Gary
Whittemore, Vicky
Hartman, Adam L.
author_facet Cervenka, Mackenzie
Pascual, Juan M.
Rho, Jong M.
Thiele, Elizabeth
Yellen, Gary
Whittemore, Vicky
Hartman, Adam L.
author_sort Cervenka, Mackenzie
collection PubMed
description OBJECTIVE: Thousands of years after dietary therapy was proposed to treat seizures, how alterations in metabolism relates to epilepsy remains unclear, and metabolism‐based therapies are not always effective. METHODS: We consider the state of the science in metabolism‐based therapies for epilepsy across the research lifecycle from basic to translational to clinical studies. RESULTS: This analysis creates a conceptual framework for creative, rigorous, and transparent research to benefit people with epilepsy through the understanding and modification of metabolism. INTERPRETATION: Despite intensive past efforts to evaluate metabolism‐based therapies for epilepsy, distinct ways of framing a problem offer the chance to engage different mindsets and new (or newly applied) technologies. A comprehensive, creative, and inclusive problem‐directed research agenda is needed, with a renewed and stringent adherence to rigor and transparency across all levels of investigation.
format Online
Article
Text
id pubmed-8351378
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-83513782021-08-15 Metabolism‐based therapies for epilepsy: new directions for future cures Cervenka, Mackenzie Pascual, Juan M. Rho, Jong M. Thiele, Elizabeth Yellen, Gary Whittemore, Vicky Hartman, Adam L. Ann Clin Transl Neurol Point of View OBJECTIVE: Thousands of years after dietary therapy was proposed to treat seizures, how alterations in metabolism relates to epilepsy remains unclear, and metabolism‐based therapies are not always effective. METHODS: We consider the state of the science in metabolism‐based therapies for epilepsy across the research lifecycle from basic to translational to clinical studies. RESULTS: This analysis creates a conceptual framework for creative, rigorous, and transparent research to benefit people with epilepsy through the understanding and modification of metabolism. INTERPRETATION: Despite intensive past efforts to evaluate metabolism‐based therapies for epilepsy, distinct ways of framing a problem offer the chance to engage different mindsets and new (or newly applied) technologies. A comprehensive, creative, and inclusive problem‐directed research agenda is needed, with a renewed and stringent adherence to rigor and transparency across all levels of investigation. John Wiley and Sons Inc. 2021-07-11 /pmc/articles/PMC8351378/ /pubmed/34247456 http://dx.doi.org/10.1002/acn3.51423 Text en © 2021 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. This article has been contributed to by US Government employees and their work is in the public domain in the USA https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Point of View
Cervenka, Mackenzie
Pascual, Juan M.
Rho, Jong M.
Thiele, Elizabeth
Yellen, Gary
Whittemore, Vicky
Hartman, Adam L.
Metabolism‐based therapies for epilepsy: new directions for future cures
title Metabolism‐based therapies for epilepsy: new directions for future cures
title_full Metabolism‐based therapies for epilepsy: new directions for future cures
title_fullStr Metabolism‐based therapies for epilepsy: new directions for future cures
title_full_unstemmed Metabolism‐based therapies for epilepsy: new directions for future cures
title_short Metabolism‐based therapies for epilepsy: new directions for future cures
title_sort metabolism‐based therapies for epilepsy: new directions for future cures
topic Point of View
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8351378/
https://www.ncbi.nlm.nih.gov/pubmed/34247456
http://dx.doi.org/10.1002/acn3.51423
work_keys_str_mv AT cervenkamackenzie metabolismbasedtherapiesforepilepsynewdirectionsforfuturecures
AT pascualjuanm metabolismbasedtherapiesforepilepsynewdirectionsforfuturecures
AT rhojongm metabolismbasedtherapiesforepilepsynewdirectionsforfuturecures
AT thieleelizabeth metabolismbasedtherapiesforepilepsynewdirectionsforfuturecures
AT yellengary metabolismbasedtherapiesforepilepsynewdirectionsforfuturecures
AT whittemorevicky metabolismbasedtherapiesforepilepsynewdirectionsforfuturecures
AT hartmanadaml metabolismbasedtherapiesforepilepsynewdirectionsforfuturecures